Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, R.-W.
Right arrow Articles by Chuang, D.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, R.-W.
Right arrow Articles by Chuang, D.-M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 10, 6039-6042, March 5, 1999

COMMUNICATION
Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression
A PROMINENT ROLE IN NEUROPROTECTION AGAINST EXCITOTOXICITY

Ren-Wu Chen and De-Maw Chuang

From the Section on Molecular Neurobiology, Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892-1272

This study was undertaken to investigate the molecular mechanisms underlying the neuroprotective actions of lithium against glutamate excitotoxicity with a focus on the role of proapoptotic and antiapoptotic genes. Long term, but not acute, treatment of cultured cerebellar granule cells with LiCl induces a concentration-dependent decrease in mRNA and protein levels of proapoptotic p53 and Bax; conversely, mRNA and protein levels of cytoprotective Bcl-2 are remarkably increased. The ratios of Bcl-2/Bax protein levels increase by approximately 5-fold after lithium treatment for 5-7 days. Exposure of cerebellar granule cells to glutamate induces a rapid increase in p53 and Bax mRNA and protein levels with no apparent effect on Bcl-2 expression. Pretreatment with LiCl for 7 days prevents glutamate-induced increase in p53 and Bax expression and maintains Bcl-2 in an elevated state. Glutamate exposure also triggers the release of cytochrome c from the mitochondria into the cytosol. Lithium pretreatment blocks glutamate-induced cytochrome c release and cleavage of lamin B1, a nuclear substrate for caspase-3. These results strongly suggest that lithium-induced Bcl-2 up-regulation and p53 and Bax down-regulation play a prominent role in neuroprotection against excitotoxicity. Our results further suggest that lithium, in addition to its use in the treatment of bipolar depressive illness, may have an expanded use in the intervention of neurodegeneration.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
Y. Leng, M.-H. Liang, M. Ren, Z. Marinova, P. Leeds, and D.-M. Chuang
Synergistic Neuroprotective Effects of Lithium and Valproic Acid or Other Histone Deacetylase Inhibitors in Neurons: Roles of Glycogen Synthase Kinase-3 Inhibition
J. Neurosci., March 5, 2008; 28(10): 2576 - 2588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. McColl, D. W. Killilea, A. E. Hubbard, M. C. Vantipalli, S. Melov, and G. J. Lithgow
Pharmacogenetic Analysis of Lithium-induced Delayed Aging in Caenorhabditis elegans
J. Biol. Chem., January 4, 2008; 283(1): 350 - 357.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
M. Mazza, M. Di Nicola, G. D. Marca, L. Janiri, P. Bria, and S. Mazza
Bipolar Disorder and Epilepsy: A Bidirectional Relation? Neurobiological Underpinnings, Current Hypotheses, and Future Research Directions
Neuroscientist, August 1, 2007; 13(4): 392 - 404.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
E. Rockenstein, M. Torrance, A. Adame, M. Mante, P. Bar-on, J. B. Rose, L. Crews, and E. Masliah
Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3{beta} Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation
J. Neurosci., February 21, 2007; 27(8): 1981 - 1991.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. Yazlovitskaya, E. Edwards, D. Thotala, A. Fu, K. L. Osusky, W. O. Whetsell Jr., B. Boone, E. T. Shinohara, and D. E. Hallahan
Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation
Cancer Res., December 1, 2006; 66(23): 11179 - 11186.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. J. Williams, C. C. Bautista, R.-W. Chen, J. R. Dave, X.-C. M. Lu, F. C. Tortella, and J. A. Hartings
Evaluation of Gabapentin and Ethosuximide for Treatment of Acute Nonconvulsive Seizures following Ischemic Brain Injury in Rats
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 947 - 955.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-L. Chen, C.-F. Lin, C.-W. Chiang, M.-S. Jan, and Y.-S. Lin
Lithium Inhibits Ceramide- and Etoposide-Induced Protein Phosphatase 2A Methylation, Bcl-2 Dephosphorylation, Caspase-2 Activation, and Apoptosis
Mol. Pharmacol., August 1, 2006; 70(2): 510 - 517.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Sinha, Z. Wang, K. L. Ruchalski, J. S. Levine, S. Krishnan, W. Lieberthal, J. H. Schwartz, and S. C. Borkan
Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F703 - F713.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Annunziato, G. Pignataro, and G. F. Di Renzo
Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives
Pharmacol. Rev., December 1, 2004; 56(4): 633 - 654.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. E. Wood, L. T. Young, L. P. Reagan, B. Chen, and B. S. McEwen
Stress-induced structural remodeling in hippocampus: Prevention by lithium treatment
PNAS, March 16, 2004; 101(11): 3973 - 3978.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Hongisto, N. Smeds, S. Brecht, T. Herdegen, M. J. Courtney, and E. T. Coffey
Lithium Blocks the c-Jun Stress Response and Protects Neurons via Its Action on Glycogen Synthase Kinase 3
Mol. Cell. Biol., September 1, 2003; 23(17): 6027 - 6036.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Ren, V. V. Senatorov, R.-W. Chen, and D.-M. Chuang
Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model
PNAS, May 13, 2003; 100(10): 6210 - 6215.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Huang, D.-Y. Wu, G. Chen, H. Manji, and D. F. Chen
Support of Retinal Ganglion Cell Survival and Axon Regeneration by Lithium through a Bcl-2-Dependent Mechanism
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 347 - 354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Carmichael, K. L. Sugars, Y. P. Bao, and D. C. Rubinsztein
Glycogen Synthase Kinase-3beta Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington's Disease Mutation
J. Biol. Chem., September 6, 2002; 277(37): 33791 - 33798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-C. Kim, H.-T. Kim, M. Mamura, I. S. Ambudkar, K.-S. Choi, and S.-J. Kim
Tumor Necrosis Factor Induces Apoptosis in Hepatoma Cells by Increasing Ca2+ Release from the Endoplasmic Reticulum and Suppressing Bcl-2 Expression
J. Biol. Chem., August 23, 2002; 277(35): 31381 - 31389.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. J. Harrison
The neuropathology of primary mood disorder
Brain, July 1, 2002; 125(7): 1428 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
S. I. Rapoport and F. Bosetti
Do Lithium and Anticonvulsants Target the Brain Arachidonic Acid Cascade in Bipolar Disorder?
Arch Gen Psychiatry, July 1, 2002; 59(7): 592 - 596.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Watcharasit, G. N. Bijur, J. W. Zmijewski, L. Song, A. Zmijewska, X. Chen, G. V. W. Johnson, and R. S. Jope
Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage
PNAS, June 11, 2002; 99(12): 7951 - 7955.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Rossig, C. Badorff, Y. Holzmann, A. M. Zeiher, and S. Dimmeler
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
J. Biol. Chem., March 15, 2002; 277(12): 9684 - 9689.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. S. Gold and P. D. Thut
Lithium Increases Potency of Lidocaine-Induced Block of Voltage-Gated Na+ Currents in Rat Sensory Neurons in Vitro
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 705 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. N. Bijur, P. De Sarno, and R. S. Jope
Glycogen Synthase Kinase-3beta Facilitates Staurosporine- and Heat Shock-induced Apoptosis. PROTECTION BY LITHIUM
J. Biol. Chem., March 10, 2000; 275(11): 7583 - 7590.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
O. C. Ikonomov and H. K. Manji
Molecular Mechanisms Underlying Mood Stabilization in Manic-Depressive Illness: The Phenotype Challenge
Am J Psychiatry, October 1, 1999; 156(10): 1506 - 1514.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Chalecka-Franaszek and D.-M. Chuang
Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons
PNAS, July 20, 1999; 96(15): 8745 - 8750.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. DeGregorio-Rocasolano, T. Gasull, and R. Trullas
Overexpression of Neuronal Pentraxin 1 Is Involved in Neuronal Death Evoked by Low K+ in Cerebellar Granule Cells
J. Biol. Chem., January 5, 2001; 276(1): 796 - 803.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lakkaraju, J. M. Dubinsky, W. C. Low, and Y.-E. Rahman
Neurons Are Protected from Excitotoxic Death by p53 Antisense Oligonucleotides Delivered in Anionic Liposomes
J. Biol. Chem., August 17, 2001; 276(34): 32000 - 32007.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Mao, P. Hoang, and P. E. DiCorleto
Lithium Inhibits Cell Cycle Progression and Induces Stabilization of p53 in Bovine Aortic Endothelial Cells
J. Biol. Chem., July 6, 2001; 276(28): 26180 - 26188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Rossig, C. Badorff, Y. Holzmann, A. M. Zeiher, and S. Dimmeler
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
J. Biol. Chem., March 15, 2002; 277(12): 9684 - 9689.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement